The value of estimated GFR in comparison to measured GFR for the assessment of renal function in adult patients with Fabry disease

Nephrology Dialysis Transplantation

Volumn 25, Issue 8, 2010, Pages 2549-2556

  Rombach, Saskia M ^a   Baas, Marije C ^a   Ten Berge, Ineke J M ^a   Krediet, Raymond T ^a   Bemelman, Frederike J ^a   Hollak, Carla E M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

estimated GFR; Fabry disease; renal function

Indexed keywords

AGALSIDASE ALFA; AGALSIDASE BETA; CREATININE; CYSTATIN C; FRABRAZYME; IODOHIPPURATE SODIUM I 131; IOTALAMIC ACID I 125; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; HIPPURIN; ISOMERASE; LIPOCALIN; PROSTAGLANDIN R2 D-ISOMERASE; STEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ESTIMATED GLOMERULUS FILTRATION RATE; FABRY DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEASURED GLOMERULUS FILTRATION RATE; MODIFICATION OF DIET IN RENAL DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; ADOLESCENT; AGED; BLOOD; COMPARATIVE STUDY; KIDNEY; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; FABRY DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; KIDNEY; KIDNEY FUNCTION TESTS; LIPOCALINS; MALE; MIDDLE AGED; STEROLS; YOUNG ADULT;

EID: 77954801038     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq108     Document Type: Article

References (54)

1. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med 1967; 276: 1163-1167
2. Kint JA. Fabry's disease: alpha-galactosidase deficiency. Science 1970; 167: 1268-1269
3. Desnick RJ, Ioannou YA, Eng MEa-Galactosidase A deficiency: Fabry disease. In: CR Scriver, SW Beaudet AL, D Valle (eds). The Metabolic and Molecular Bases of Inherited Disease; 8 ed New York: McGraw-ill, 2001; 3: 3733-3774
4. Burkholder PM, Updike SJ, Ware RA, Reese OG. Clinicopathologic, enzymatic, and genetic features in a case of Fabry's disease. Arch Pathol Lab Med 1980; 104: 17-25
5. Donati D, Novario R, Gastaldi L. Natural history and treatment of uremia secondary to Fabry's disease: an European experience. Nephron 1987; 46: 353-359
6. Branton M, Schiffmann R, Kopp JB. Natural history and treatment of renal involvement in Fabry disease. J Am Soc Nephrol 2002; 13: S139-S143
7. Branton MH, Schiffmann R, Sabnis SG, Murray GJ, Quirk JM, Altarescu G et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) 2002; 81: 122-138
8. Eng CM, Fletcher J, Wilcox WR, Waldek S, Scott CR, Sillence DO et al. Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J Inherit Metab Dis 2007; 30: 184-192
9. West M, Nicholls K, Mehta A, Clarke JT, Steiner R, Beck M et al. Agalsidase alfa and kidney dysfunction in Fabry disease. J Am Soc Nephrol 2009; 20: 1132-1139
10. Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M et al. Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann Intern Med 2007; 146: 77-86
11. Breunig F, Weidemann F, Strotmann J, Knoll A, Wanner C. Clinical benefit of enzyme replacement therapy in Fabry disease. Kidney Int 2006; 69: 1216-1221
12. Kleinert J, Lorenz M, Hauser AC, Becherer A, Staudenherz A, Fodinger M et al. Measurement of renal function in patients with Fabry disease. Acta Paediatr Suppl 2005; 94: 19-23
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum cre- atinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
14. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11 (Abstract)
15. Aakre KM, Tondel C, Brun A, Svarstad E. The MDRD equation may mask decline of glomerular filtration rate in Fabry patients with normal or nearly normal kidney function. Clin Nephrol 2009; 71: 118-124
16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
17. Filler G, Bokenkamp A, Hofmann W, Le BT, Martinez-Bru C, Grubb A. Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 2005; 38: 1-8
18. Tenstad O, Roald AB, Grubb A, Aukland K. Renal handling of radi- olabelled human cystatin C in the rat. Scand J Clin Lab Invest 1996; 56: 409-414
19. Donadio C, Lucchesi A, Ardini M, Giordani R. Cystatin C, beta 2- microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine. J Pharm Biomed Anal 2001; 24: 835-842
20. Vinge E, Lindergard B, Nilsson-Ehle P, Grubb A. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glo- merular filtration rate in healthy adults. Scand J Clin Lab Invest 1999- 59: 587-592
21. den Hollander JG, Wulkan RW, Mantel MJ, Berghout A. Is cystatin C a marker of glomerular filtration rate in thyroid dysfunction? Clin Chem 2003; 49: 1558-1559
22. Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C. Impact ofthy- roid dysfunction on serum cystatin C. Kidney Int 2003; 63: 1944-1947
23. Wiesli P, Schwegler B, Spinas GA, Schmid C. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta 2003; 338: 87-90
24. Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexameth- asone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest 1995; 55: 617-623
25. Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta 2000; 300: 83-95
26. Poge U, Gerhardt T, Bokenkamp A, Stoffel-Wagner B, Klehr HU, Sauerbruch T et al. Time course of low molecular weight proteins in the early kidney transplantation period-influence of corticoster- oids. Nephrol Dial Transplant 2004; 19: 2858-2863
27. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cysta- tin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003; 18: 2024-2031
28. Feriozzi S, Germain DP, Di VR, Legrand A, Ricci R, Barbey F. Cy- statin C as a marker of early changes of renal function in Fabry ne- phropathy. J Nephrol 2007; 20: 437-443
29. Hoffmann A, Nimtz M, Conradt HS. Molecular characterization of beta-trace protein in human serum and urine: a potential diagnostic marker for renal diseases. Glycobiology 1997; 7: 499-506
30. Kobata M, Shimizu A, Rinno H, Hamada C, Maeda K, Fukui M et al. Beta-trace protein, a new marker of GFR, may predict the early prognostic stages ofpatients with type 2 diabetic nephropathy. J Clin Lab Anal 2004; 18: 237-239
31. Poge U, Gerhardt TM, Stoffel-Wagner B, Palmedo H, Klehr HU, Sauerbruch T et al. beta-Trace protein is an alternative marker for glomerular filtration rate in renal transplantation patients. Clin Chem 2005; 51: 1531-1533
32. Priem F, Althaus H, Birnbaum M, Sinha P, Conradt HS, Jung K. beta- Trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range. Clin Chem 1999; 45: 567-568
33. Abbink FC, Laarman CA, Braam KI, van Wijk JA, Kors WA, Bouman AA et al. beta-Trace protein is not superior to cystatin C for the estimation of GFR in patients receiving corticosteroids. Clin Biochem 2008; 41: 299-305
34. Apperloo AJ, de Zeeuw D, Donker AJ, de Jong PE. Precision of glo- merular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I- hippuran. J Am Soc Nephrol 1996; 7: 567-572
35. Donker AJ, van der Hem GK, Sluiter WJ, Beekhuis H. A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med 1977; 20: 97-103
36. Michels WM, Grootendorst DC, Rozemeijer K, Dekker FW, Krediet RT. Glomerular filtration rate measurements by 125I-iothalamate should be corrected for inaccurate urine collections with 131I-hippur- an. Clin Nephrol 2009; 72: 337-343
37. Vedder AC, Linthorst GE, Houge G, Groener JE, Ormel EE, Bouma BJ et al. Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg. PLoS ONE 2007; 2: e598
38. Vedder AC, Breunig F, Donker-Koopman WE, Mills K, Young E, Winchester B. Treatment of Fabry disease with different dosing regi mens of agalsidase: effects on antibody formation and GL-3. Mol Genet Metab 2008; 94: 319-325
39. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
40. Larsson A, Malm J, Grubb A, Hansson LO. Calculation of glomeru- lar filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 2004; 64: 25-30
41. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254
42. Poge U, Gerhardt T, Stoffel-Wagner B, Palmedo H, Klehr HU, Sauerbruch T et al. beta-Trace protein-based equations for calculation of GFR in renal transplant recipients. Am J Transplant 2008; 8: 608-615 (Pubitemid 351287548)
43. Rule AD, Bergstralh EJ, Slezak JM, Bergert J, Larson TS. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int 2006; 69: 399-405
44. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: 395-406
45. White CA, Akbari A, Doucette S, Fergusson D, Hussain N, Dinh L et al. A novel equation to estimate glomerular filtration rate using beta-trace protein. Clin Chem 2007; 53: 1965-1968
46. Du Bois D DBE. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-871
47. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310
48. Bland JM, Altman DG. Agreement between methods ofmeasurement with multiple observations per individual. JBiopharm Stat 2007; 17: 571-582
49. Orskov B, Borresen ML, Feldt-Rasmussen B, Ostergaard O, Laursen IStrandgaard S. Estimating glomerular filtration rate using the new CKD-EPI equation and other equations in patients with au- tosomal dominant polycystic kidney disease. Am J Nephrol 2010; 31: 53-57
50. Stevens LA, Schmid CH, Zhang YL, Coresh J, Manzi J, Landis R et al. Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant 2010; 25: 449-457
51. White CA, Akbari A, Doucette D, Fergusson D, Knoll GA. Estimating glomerular filtration rate in kidney transplantation: is the new Chronic Kidney Disease Epidemiology Collaboration equation any better? Clin Chem 2010; 56: 474-477
52. Poggio ED, Wang X, Greene T, Van LF, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005; 16: 459-466 (Pubitemid 41725142)
53. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 929-937
54. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009; 75: 652-660